Literature DB >> 24619412

Histone deacetylase-3 mediates positive feedback relationship between anaphylaxis and tumor metastasis.

Sangkyung Eom1, Youngmi Kim, Deokbum Park, Hansoo Lee, Yun Sil Lee, Jongseon Choe, Young Myeong Kim, Dooil Jeoung.   

Abstract

Allergic inflammation has been known to enhance the metastatic potential of tumor cells. The role of histone deacetylase-3 (HDAC3) in allergic skin inflammation was reported. We investigated HDAC3 involvement in the allergic inflammation-promotion of metastatic potential of tumor cells. Passive systemic anaphylaxis (PSA) induced HDAC3 expression and FcεRI signaling in BALB/c mice. PSA enhanced the tumorigenic and metastatic potential of mouse melanoma cells in HDAC3- and monocyte chemoattractant protein 1-(MCP1)-dependent manner. The PSA-mediated enhancement of metastatic potential involved the induction of HDAC3, MCP1, and CD11b (a macrophage marker) expression in the lung tumor tissues. We examined an interaction between anaphylaxis and tumor growth and metastasis at the molecular level. Conditioned medium from antigen-stimulated bone marrow-derived mouse mast cell cultures induced the expression of HDAC3, MCP1, and CCR2, a receptor for MCP1, in B16F1 mouse melanoma cells and enhanced migration and invasion potential of B16F1 cells. The conditioned medium from B16F10 cultures induced the activation of FcεRI signaling in lung mast cells in an HDAC3-dependent manner. FcεRI signaling was observed in lung tumors derived from B16F10 cells. Target scan analysis predicted HDAC3 to be as a target of miR-384, and miR-384 and HDAC3 were found to form a feedback regulatory loop. miR-384, which is decreased by PSA, negatively regulated HDAC3 expression, allergic inflammation, and the positive feedback regulatory loop between anaphylaxis and tumor metastasis. We show the miR-384/HDAC3 feedback loop to be a novel regulator of the positive feedback relationship between anaphylaxis and tumor metastasis.

Entities:  

Keywords:  Allergy; Anaphylaxis; Cell-Cell Interaction; Histone Deacetylase; Histone Deacetylase-3; MicroRNA; MicroRNA-384; Positive Feedback Regulatory Loop; Tumor Metastases

Mesh:

Substances:

Year:  2014        PMID: 24619412      PMCID: PMC4002117          DOI: 10.1074/jbc.M113.521245

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis.

Authors:  S Huerta-Yepez; G J Baay-Guzman; I G Bebenek; R Hernandez-Pando; M I Vega; L Chi; M Riedl; D Diaz-Sanchez; E Kleerup; D P Tashkin; F J Gonzalez; B Bonavida; M Zeidler; Oliver Hankinson
Journal:  Allergy       Date:  2011-04-26       Impact factor: 13.146

2.  Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5.

Authors:  Ronaldo Paolo L Panganiban; Mark H Pinkerton; Saumya Y Maru; Sarah J Jefferson; Alanna N Roff; Faoud T Ishmael
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

3.  Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib.

Authors:  H Mizuno; T Nakayama; Y Miyata; S Saito; S Nishiwaki; N Nakao; K Takeshita; T Naoe
Journal:  Leukemia       Date:  2012-03-20       Impact factor: 11.528

4.  Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model.

Authors:  Amit Sharma; Manish Kumar; Tanveer Ahmad; Ulaganathan Mabalirajan; Jyotirmoi Aich; Anurag Agrawal; Balaram Ghosh
Journal:  J Appl Physiol (1985)       Date:  2012-06-14

5.  SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.

Authors:  Bo Huang; Zhang Lei; Gui-Mei Zhang; Dong Li; Chuanwang Song; Bo Li; Yanyan Liu; Ye Yuan; Jay Unkeless; Huabao Xiong; Zuo-Hua Feng
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

6.  Mast cells play a protumorigenic role in primary cutaneous lymphoma.

Authors:  Anja Rabenhorst; Max Schlaak; Lukas C Heukamp; Anja Förster; Sebastian Theurich; Michael von Bergwelt-Baildon; Reinhard Büttner; Peter Kurschat; Cornelia Mauch; Axel Roers; Karin Hartmann
Journal:  Blood       Date:  2012-07-26       Impact factor: 22.113

7.  Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions.

Authors:  Kalyan Pande; Roanna Ueda; Todd Machemer; Manjiri Sathe; Van Tsai; Elena Brin; Matthew J Delano; Nico Van Rooijen; Terrill K McClanahan; James E Talmadge; Lyle L Moldawer; Joseph H Phillips; Drake M LaFace
Journal:  Mol Ther       Date:  2009-01-06       Impact factor: 11.454

8.  Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors.

Authors:  Laura Soucek; Elizabeth R Lawlor; Darya Soto; Ksenya Shchors; Lamorna Brown Swigart; Gerard I Evan
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

9.  Mast cells in pancreatic ductal adenocarcinoma.

Authors:  David Z Chang
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

10.  Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model.

Authors:  Yi-Rang Na; Yi-Na Yoon; Da-In Son; Seung-Hyeok Seok
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more
  14 in total

1.  MicroRNA-26a/-26b-COX-2-MIP-2 Loop Regulates Allergic Inflammation and Allergic Inflammation-promoted Enhanced Tumorigenic and Metastatic Potential of Cancer Cells.

Authors:  Yoojung Kwon; Youngmi Kim; Sangkyung Eom; Misun Kim; Deokbum Park; Hyuna Kim; Kyeonga Noh; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

2.  Transglutaminase II/microRNA-218/-181a loop regulates positive feedback relationship between allergic inflammation and tumor metastasis.

Authors:  Sangkyung Eom; Youngmi Kim; Misun Kim; Deokbum Park; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

3.  LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.

Authors:  Qiuhong Ma; Xiangqin Qi; Xiaona Lin; Liang Li; Libo Chen; Wei Hu
Journal:  Hum Cell       Date:  2019-10-04       Impact factor: 4.174

Review 4.  The Hyaluronic Acid-HDAC3-miRNA Network in Allergic Inflammation.

Authors:  Youngmi Kim; Sangkyung Eom; Deokbum Park; Hyuna Kim; Dooil Jeoung
Journal:  Front Immunol       Date:  2015-04-30       Impact factor: 7.561

5.  MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.

Authors:  Yong-Xia Wang; Yan-Ru Chen; Shan-Shan Liu; Ya-Ping Ye; Hong-Li Jiao; Shu-Yang Wang; Zhi-Yuan Xiao; Wen-Ting Wei; Jun-Feng Qiu; Li Liang; Wen-Ting Liao; Yan-Qing Ding
Journal:  Oncotarget       Date:  2016-12-20

6.  Effects of anticholinergic agent on miRNA profiles and transcriptomes in a murine model of allergic rhinitis.

Authors:  Minghua Hou; Wei Li; Zuozhong Xie; Jingang Ai; Bo Sun; Guolin Tan
Journal:  Mol Med Rep       Date:  2017-08-31       Impact factor: 2.952

7.  MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1.

Authors:  Yongxia Wang; Zheying Zhang; Jianqiang Wang
Journal:  Oncol Rep       Date:  2018-04-20       Impact factor: 3.906

8.  miR-122-SOCS1-JAK2 axis regulates allergic inflammation and allergic inflammation-promoted cellular interactions.

Authors:  Kyeonga Noh; Misun Kim; Youngmi Kim; Hanearl Kim; Hyuna Kim; Jaehwan Byun; Yeongseo Park; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  Oncotarget       Date:  2017-07-10

9.  Homoharringtonine Inhibits Allergic Inflammations by Regulating NF-κB-miR-183-5p-BTG1 Axis.

Authors:  Misun Kim; Hyein Jo; Yoojung Kwon; Youngmi Kim; Hyun Suk Jung; Dooil Jeoung
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

10.  MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3.

Authors:  Yong-Xia Wang; Hui-Fang Zhu; Zhe-Ying Zhang; Feng Ren; Yu-Han Hu
Journal:  Cancer Cell Int       Date:  2018-09-03       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.